| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | LRP2 HSPG2 THBD HABP2 LTBP1 FAT2 EGFL7 MEGF6 MEGF8 AGRN LETM1 NOTCH3 | 5.21e-10 | 749 | 31 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.27e-08 | 188 | 31 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.81e-05 | 891 | 31 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 7.41e-04 | 26 | 31 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | Notch binding | 7.99e-04 | 27 | 31 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 1.27e-03 | 34 | 31 | 2 | GO:0050750 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.67e-03 | 39 | 31 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.79e-03 | 156 | 31 | 3 | GO:0019838 | |
| GeneOntologyBiologicalProcess | axon guidance | 7.44e-12 | 285 | 31 | 10 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 7.70e-12 | 286 | 31 | 10 | GO:0097485 | |
| GeneOntologyBiologicalProcess | axonogenesis | 5.90e-09 | 566 | 31 | 10 | GO:0007409 | |
| GeneOntologyBiologicalProcess | axon development | 1.96e-08 | 642 | 31 | 10 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 8.23e-08 | 748 | 31 | 10 | GO:0048667 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.58e-07 | 802 | 31 | 10 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.92e-07 | 819 | 31 | 10 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.07e-07 | 826 | 31 | 10 | GO:0048858 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 5.90e-06 | 1194 | 31 | 10 | GO:0000902 | |
| GeneOntologyBiologicalProcess | neuron projection development | 1.13e-05 | 1285 | 31 | 10 | GO:0031175 | |
| GeneOntologyBiologicalProcess | neuron development | 3.49e-05 | 1463 | 31 | 10 | GO:0048666 | |
| GeneOntologyBiologicalProcess | artery development | 4.54e-05 | 133 | 31 | 4 | GO:0060840 | |
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 4.57e-05 | 7 | 31 | 2 | GO:0043654 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 2.08e-04 | 197 | 31 | 4 | GO:0030509 | |
| GeneOntologyBiologicalProcess | aorta development | 2.34e-04 | 80 | 31 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 2.60e-04 | 83 | 31 | 3 | GO:0060976 | |
| GeneOntologyBiologicalProcess | response to BMP | 2.90e-04 | 215 | 31 | 4 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 2.90e-04 | 215 | 31 | 4 | GO:0071773 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 2.93e-04 | 17 | 31 | 2 | GO:0048841 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 3.53e-04 | 92 | 31 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.89e-04 | 445 | 31 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 4.96e-04 | 22 | 31 | 2 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 4.96e-04 | 22 | 31 | 2 | GO:1902284 | |
| GeneOntologyBiologicalProcess | negative regulation of ATP-dependent activity | 5.42e-04 | 23 | 31 | 2 | GO:0032780 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 7.02e-04 | 482 | 31 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | response to X-ray | 9.26e-04 | 30 | 31 | 2 | GO:0010165 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 9.88e-04 | 131 | 31 | 3 | GO:0030510 | |
| GeneOntologyBiologicalProcess | axon extension | 1.08e-03 | 135 | 31 | 3 | GO:0048675 | |
| GeneOntologyBiologicalProcess | gastrulation with mouth forming second | 1.26e-03 | 35 | 31 | 2 | GO:0001702 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 1.62e-03 | 1190 | 31 | 7 | GO:0008284 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.73e-03 | 347 | 31 | 4 | GO:0090092 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.77e-09 | 530 | 31 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.11e-08 | 656 | 31 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.18e-08 | 658 | 31 | 10 | GO:0030312 | |
| GeneOntologyCellularComponent | basement membrane | 2.28e-08 | 122 | 31 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 3.52e-07 | 10 | 31 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | laminin-3 complex | 6.38e-06 | 3 | 31 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.27e-05 | 4 | 31 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | phagocytic cup | 9.64e-04 | 31 | 31 | 2 | GO:0001891 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.09e-03 | 33 | 31 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | axonal growth cone | 2.03e-03 | 45 | 31 | 2 | GO:0044295 | |
| HumanPheno | Abnormal sternum morphology | 3.20e-05 | 474 | 20 | 9 | HP:0000766 | |
| HumanPheno | Diaphragmatic eventration | 6.58e-05 | 21 | 20 | 3 | HP:0009110 | |
| HumanPheno | Abnormality of the scalp hair | 1.29e-04 | 433 | 20 | 8 | HP:0100037 | |
| HumanPheno | Renal tubular epithelial necrosis | 1.45e-04 | 5 | 20 | 2 | HP:0008682 | |
| HumanPheno | Renal necrosis | 1.45e-04 | 5 | 20 | 2 | HP:0032618 | |
| HumanPheno | Pyoderma | 1.45e-04 | 5 | 20 | 2 | HP:0000999 | |
| HumanPheno | Abnormal scalp morphology | 1.69e-04 | 450 | 20 | 8 | HP:0001965 | |
| MousePheno | abnormal amacrine cell morphology | 4.52e-07 | 31 | 29 | 4 | MP:0005240 | |
| MousePheno | abnormal thoracic aorta morphology | 7.41e-06 | 134 | 29 | 5 | MP:0010468 | |
| MousePheno | abnormal ascending aorta and coronary artery attachment | 1.25e-05 | 3 | 29 | 2 | MP:0010472 | |
| MousePheno | abnormal somatic nervous system morphology | PLXNA4 LAMB2 HSPG2 LAMC3 CRIM1 MEGF8 PRICKLE3 AGRN FAM161A MEGF10 | 2.37e-05 | 1025 | 29 | 10 | MP:0002752 |
| MousePheno | abnormal glomerular filtration barrier function | 2.49e-05 | 4 | 29 | 2 | MP:0011856 | |
| MousePheno | abnormal coronary artery morphology | 2.83e-05 | 29 | 29 | 3 | MP:0004111 | |
| MousePheno | abnormal kidney morphology | BSND LRP2 KCP TRMT1 LAMB2 LAMC2 THBD LTBP1 CRIM1 MEGF8 NOTCH3 | 4.79e-05 | 1363 | 29 | 11 | MP:0002135 |
| MousePheno | abnormal basal lamina morphology | 6.20e-05 | 6 | 29 | 2 | MP:0004273 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 6.20e-05 | 6 | 29 | 2 | MP:0001054 | |
| MousePheno | abnormal basement membrane morphology | 7.53e-05 | 40 | 29 | 3 | MP:0004272 | |
| MousePheno | abnormal aorta morphology | 8.95e-05 | 225 | 29 | 5 | MP:0000272 | |
| MousePheno | abnormal aortic arch morphology | 1.01e-04 | 119 | 29 | 4 | MP:0004113 | |
| MousePheno | abnormal cardiac outflow tract development | 1.59e-04 | 134 | 29 | 4 | MP:0006126 | |
| MousePheno | abnormal cardiovascular development | 1.65e-04 | 802 | 29 | 8 | MP:0002925 | |
| MousePheno | abnormal trigeminal nerve morphology | 1.66e-04 | 52 | 29 | 3 | MP:0001065 | |
| MousePheno | short snout | 1.69e-04 | 136 | 29 | 4 | MP:0000445 | |
| MousePheno | small snout | 2.10e-04 | 144 | 29 | 4 | MP:0030190 | |
| MousePheno | decreased airway resistance | 2.26e-04 | 11 | 29 | 2 | MP:0010936 | |
| MousePheno | abnormal artery morphology | 2.41e-04 | 440 | 29 | 6 | MP:0002191 | |
| MousePheno | abnormal coronary vessel morphology | 2.41e-04 | 59 | 29 | 3 | MP:0010551 | |
| MousePheno | right aortic arch | 2.54e-04 | 60 | 29 | 3 | MP:0004158 | |
| MousePheno | abnormal sensory neuron morphology | 3.56e-04 | 473 | 29 | 6 | MP:0000965 | |
| MousePheno | abnormal systemic artery morphology | 3.64e-04 | 304 | 29 | 5 | MP:0011655 | |
| MousePheno | abnormal somatic sensory system morphology | 4.62e-04 | 702 | 29 | 7 | MP:0000959 | |
| MousePheno | abnormal blood vessel morphology | LRP2 TRMT1 HSPG2 LTBP1 EGFL7 CRIM1 MEGF8 PRICKLE3 FAM161A NOTCH3 | 4.97e-04 | 1472 | 29 | 10 | MP:0001614 |
| MousePheno | muscular ventricular septal defect | 5.30e-04 | 77 | 29 | 3 | MP:0010420 | |
| MousePheno | abnormal interventricular septum muscular part morphology | 5.71e-04 | 79 | 29 | 3 | MP:0010498 | |
| MousePheno | abnormal retina morphology | PLXNA4 TRMT1 LAMB2 LAMC3 EGFL7 PRICKLE3 FAM161A MEGF10 NOTCH3 | 5.96e-04 | 1227 | 29 | 9 | MP:0001325 |
| MousePheno | abnormal jaw morphology | 6.51e-04 | 530 | 29 | 6 | MP:0000454 | |
| MousePheno | abnormal ocular fundus morphology | PLXNA4 TRMT1 LAMB2 LAMC3 EGFL7 PRICKLE3 FAM161A MEGF10 NOTCH3 | 7.33e-04 | 1262 | 29 | 9 | MP:0002864 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 7.63e-04 | 1269 | 29 | 9 | MP:0011111 | |
| MousePheno | abnormal heart and great artery attachment | 8.00e-04 | 205 | 29 | 4 | MP:0010426 | |
| MousePheno | abnormal heart and great vessel attachment | 8.45e-04 | 208 | 29 | 4 | MP:0010425 | |
| MousePheno | renal glomerulus cyst | 8.52e-04 | 21 | 29 | 2 | MP:0011682 | |
| MousePheno | perimembraneous ventricular septal defect | 8.90e-04 | 92 | 29 | 3 | MP:0010418 | |
| MousePheno | abnormal angiogenesis | 9.11e-04 | 372 | 29 | 5 | MP:0000260 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 9.19e-04 | 93 | 29 | 3 | MP:0008823 | |
| MousePheno | abnormal skeletal muscle size | 9.19e-04 | 93 | 29 | 3 | MP:0009458 | |
| MousePheno | abnormal glossopharyngeal nerve morphology | 9.36e-04 | 22 | 29 | 2 | MP:0001073 | |
| MousePheno | abnormal ascending aorta morphology | 9.36e-04 | 22 | 29 | 2 | MP:0009867 | |
| MousePheno | abnormal neuromuscular synapse morphology | 9.77e-04 | 95 | 29 | 3 | MP:0001053 | |
| MousePheno | abnormal somatic motor system morphology | 1.07e-03 | 98 | 29 | 3 | MP:0001051 | |
| MousePheno | abnormal cranium morphology | 1.11e-03 | 813 | 29 | 7 | MP:0000438 | |
| MousePheno | blistering | 1.11e-03 | 24 | 29 | 2 | MP:0001208 | |
| MousePheno | abnormal retina vasculature morphology | 1.13e-03 | 390 | 29 | 5 | MP:0002792 | |
| MousePheno | abnormal extracellular matrix morphology | 1.13e-03 | 100 | 29 | 3 | MP:0013258 | |
| MousePheno | abnormal renal tubule morphology | 1.17e-03 | 227 | 29 | 4 | MP:0002703 | |
| MousePheno | abnormal viscerocranium morphology | 1.17e-03 | 593 | 29 | 6 | MP:0005274 | |
| MousePheno | increased inflammatory response | 1.20e-03 | 1077 | 29 | 8 | MP:0001846 | |
| MousePheno | abnormal craniofacial bone morphology | 1.22e-03 | 827 | 29 | 7 | MP:0002116 | |
| MousePheno | abnormal retina blood vessel morphology | 1.31e-03 | 234 | 29 | 4 | MP:0010097 | |
| MousePheno | abnormal miniature endplate potential | 1.31e-03 | 26 | 29 | 2 | MP:0004835 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 1.41e-03 | 27 | 29 | 2 | MP:0011409 | |
| MousePheno | hydronephrosis | 1.45e-03 | 109 | 29 | 3 | MP:0000519 | |
| MousePheno | abnormal eye vasculature morphology | 1.48e-03 | 415 | 29 | 5 | MP:0031346 | |
| MousePheno | abnormal renal glomerular filtration | 1.63e-03 | 29 | 29 | 2 | MP:0013284 | |
| MousePheno | abnormal vagus nerve morphology | 1.63e-03 | 29 | 29 | 2 | MP:0001074 | |
| MousePheno | abnormal snout morphology | 1.85e-03 | 257 | 29 | 4 | MP:0000443 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 1.86e-03 | 31 | 29 | 2 | MP:0011349 | |
| MousePheno | ventricular septal defect | 1.95e-03 | 261 | 29 | 4 | MP:0010402 | |
| MousePheno | postnatal lethality, complete penetrance | 2.02e-03 | 445 | 29 | 5 | MP:0011085 | |
| MousePheno | abnormal axial skeleton morphology | 2.06e-03 | 1458 | 29 | 9 | MP:0002114 | |
| MousePheno | abnormal kidney pelvis morphology | 2.10e-03 | 124 | 29 | 3 | MP:0004194 | |
| MousePheno | abnormal mouth morphology | 2.19e-03 | 670 | 29 | 6 | MP:0000452 | |
| MousePheno | abnormal PNS synaptic transmission | 2.37e-03 | 35 | 29 | 2 | MP:0002913 | |
| MousePheno | vascular ring | 2.37e-03 | 35 | 29 | 2 | MP:0010466 | |
| MousePheno | decreased bone mineral content | 2.44e-03 | 465 | 29 | 5 | MP:0010124 | |
| MousePheno | abnormal enzyme/coenzyme activity | 2.76e-03 | 287 | 29 | 4 | MP:0005584 | |
| Domain | EGF_1 | LRP2 LAMA3 LAMB2 HSPG2 LAMC2 LAMC3 THBD HABP2 LTBP1 FAT2 EGFL7 MEGF6 MEGF8 SSPOP AGRN MEGF10 NOTCH3 PEAR1 | 2.61e-26 | 255 | 31 | 18 | PS00022 |
| Domain | EGF_2 | LRP2 LAMA3 LAMB2 HSPG2 LAMC2 LAMC3 THBD HABP2 LTBP1 FAT2 EGFL7 MEGF6 MEGF8 SSPOP AGRN MEGF10 NOTCH3 PEAR1 | 5.31e-26 | 265 | 31 | 18 | PS01186 |
| Domain | EGF | LRP2 LAMA3 LAMB2 HSPG2 LAMC2 LAMC3 THBD HABP2 LTBP1 FAT2 EGFL7 MEGF6 MEGF8 AGRN MEGF10 NOTCH3 PEAR1 | 6.28e-25 | 235 | 31 | 17 | SM00181 |
| Domain | EGF-like_dom | LRP2 LAMA3 LAMB2 HSPG2 LAMC2 LAMC3 THBD HABP2 LTBP1 FAT2 EGFL7 MEGF6 MEGF8 AGRN MEGF10 NOTCH3 PEAR1 | 1.72e-24 | 249 | 31 | 17 | IPR000742 |
| Domain | EGF-like_CS | LRP2 LAMA3 LAMB2 HSPG2 LAMC2 LAMC3 THBD HABP2 LTBP1 FAT2 EGFL7 MEGF6 MEGF8 AGRN MEGF10 NOTCH3 PEAR1 | 3.90e-24 | 261 | 31 | 17 | IPR013032 |
| Domain | Laminin_EGF | 5.59e-21 | 35 | 31 | 10 | PF00053 | |
| Domain | EGF_Lam | 5.59e-21 | 35 | 31 | 10 | SM00180 | |
| Domain | Laminin_EGF | 1.43e-20 | 38 | 31 | 10 | IPR002049 | |
| Domain | Growth_fac_rcpt_ | LRP2 LAMA3 LAMB2 HSPG2 LAMC2 LAMC3 THBD LTBP1 EGFL7 CRIM1 MEGF6 MEGF8 NOTCH3 | 1.05e-19 | 156 | 31 | 13 | IPR009030 |
| Domain | EGF_3 | LRP2 HSPG2 THBD HABP2 LTBP1 FAT2 EGFL7 MEGF6 MEGF8 SSPOP AGRN MEGF10 NOTCH3 PEAR1 | 3.70e-19 | 235 | 31 | 14 | PS50026 |
| Domain | EGF_CA | LRP2 HSPG2 THBD HABP2 LTBP1 FAT2 EGFL7 MEGF6 MEGF8 AGRN NOTCH3 | 4.42e-17 | 122 | 31 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | LRP2 HSPG2 THBD HABP2 LTBP1 FAT2 EGFL7 MEGF6 MEGF8 AGRN NOTCH3 | 5.32e-17 | 124 | 31 | 11 | IPR001881 |
| Domain | EGF_LAM_2 | 3.32e-14 | 30 | 31 | 7 | PS50027 | |
| Domain | EGF_LAM_1 | 3.32e-14 | 30 | 31 | 7 | PS01248 | |
| Domain | EGF | 3.85e-13 | 126 | 31 | 9 | PF00008 | |
| Domain | EMI | 5.48e-11 | 17 | 31 | 5 | PS51041 | |
| Domain | EGF_CA | 8.23e-11 | 86 | 31 | 7 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.94e-10 | 97 | 31 | 7 | IPR018097 | |
| Domain | EGF_CA | 2.25e-10 | 99 | 31 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.41e-10 | 100 | 31 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.65e-10 | 106 | 31 | 7 | IPR000152 | |
| Domain | LAMININ_IVA | 4.33e-10 | 8 | 31 | 4 | PS51115 | |
| Domain | Laminin_B | 4.33e-10 | 8 | 31 | 4 | PF00052 | |
| Domain | LamB | 4.33e-10 | 8 | 31 | 4 | SM00281 | |
| Domain | Laminin_IV | 4.33e-10 | 8 | 31 | 4 | IPR000034 | |
| Domain | EMI_domain | 1.11e-08 | 16 | 31 | 4 | IPR011489 | |
| Domain | EGF_extracell | 4.60e-08 | 60 | 31 | 5 | IPR013111 | |
| Domain | EGF_2 | 4.60e-08 | 60 | 31 | 5 | PF07974 | |
| Domain | LAM_G_DOMAIN | 4.41e-07 | 38 | 31 | 4 | PS50025 | |
| Domain | LamG | 8.05e-07 | 44 | 31 | 4 | SM00282 | |
| Domain | TIL_dom | 1.49e-06 | 14 | 31 | 3 | IPR002919 | |
| Domain | LAMININ_NTER | 2.28e-06 | 16 | 31 | 3 | PS51117 | |
| Domain | Laminin_N | 2.28e-06 | 16 | 31 | 3 | PF00055 | |
| Domain | Laminin_N | 2.28e-06 | 16 | 31 | 3 | IPR008211 | |
| Domain | LamNT | 2.28e-06 | 16 | 31 | 3 | SM00136 | |
| Domain | Laminin_G | 2.47e-06 | 58 | 31 | 4 | IPR001791 | |
| Domain | VWC_out | 3.94e-06 | 19 | 31 | 3 | SM00215 | |
| Domain | cEGF | 1.05e-05 | 26 | 31 | 3 | IPR026823 | |
| Domain | cEGF | 1.05e-05 | 26 | 31 | 3 | PF12662 | |
| Domain | hEGF | 1.32e-05 | 28 | 31 | 3 | PF12661 | |
| Domain | - | 1.78e-05 | 95 | 31 | 4 | 2.60.120.200 | |
| Domain | VWFC_1 | 2.85e-05 | 36 | 31 | 3 | PS01208 | |
| Domain | VWC | 3.36e-05 | 38 | 31 | 3 | SM00214 | |
| Domain | VWFC_2 | 3.36e-05 | 38 | 31 | 3 | PS50184 | |
| Domain | Laminin_G_2 | 3.92e-05 | 40 | 31 | 3 | PF02210 | |
| Domain | LDLR_class-A_CS | 3.92e-05 | 40 | 31 | 3 | IPR023415 | |
| Domain | VWF_dom | 4.55e-05 | 42 | 31 | 3 | IPR001007 | |
| Domain | Ldl_recept_a | 5.60e-05 | 45 | 31 | 3 | PF00057 | |
| Domain | - | 5.99e-05 | 46 | 31 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 6.81e-05 | 48 | 31 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 7.24e-05 | 49 | 31 | 3 | IPR002172 | |
| Domain | LDLa | 7.24e-05 | 49 | 31 | 3 | SM00192 | |
| Domain | LDLRA_2 | 7.24e-05 | 49 | 31 | 3 | PS50068 | |
| Domain | Laminin_G_1 | 1.45e-04 | 11 | 31 | 2 | PF00054 | |
| Domain | Unchr_dom_Cys-rich | 2.06e-04 | 13 | 31 | 2 | IPR014853 | |
| Domain | C8 | 2.06e-04 | 13 | 31 | 2 | SM00832 | |
| Domain | SEA | 2.40e-04 | 14 | 31 | 2 | SM00200 | |
| Domain | VWFD | 3.15e-04 | 16 | 31 | 2 | PS51233 | |
| Domain | VWD | 3.15e-04 | 16 | 31 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.15e-04 | 16 | 31 | 2 | IPR001846 | |
| Domain | VWD | 3.15e-04 | 16 | 31 | 2 | PF00094 | |
| Domain | ConA-like_dom | 4.51e-04 | 219 | 31 | 4 | IPR013320 | |
| Domain | Galactose-bd-like | 5.01e-04 | 94 | 31 | 3 | IPR008979 | |
| Domain | SEA | 6.03e-04 | 22 | 31 | 2 | PF01390 | |
| Domain | SEA | 6.60e-04 | 23 | 31 | 2 | PS50024 | |
| Domain | SEA_dom | 6.60e-04 | 23 | 31 | 2 | IPR000082 | |
| Domain | VWC | 9.81e-04 | 28 | 31 | 2 | PF00093 | |
| Domain | Plexin_repeat | 1.28e-03 | 32 | 31 | 2 | IPR002165 | |
| Domain | PSI | 1.28e-03 | 32 | 31 | 2 | PF01437 | |
| Domain | PSI | 2.42e-03 | 44 | 31 | 2 | IPR016201 | |
| Domain | PSI | 2.64e-03 | 46 | 31 | 2 | SM00423 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.95e-10 | 59 | 23 | 6 | M27218 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.01e-09 | 30 | 23 | 5 | M27216 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.48e-09 | 84 | 23 | 6 | M7098 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.43e-07 | 30 | 23 | 4 | M27772 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.37e-07 | 300 | 23 | 7 | M610 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.24e-07 | 41 | 23 | 4 | M27778 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 6.21e-07 | 11 | 23 | 3 | M158 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 8.40e-07 | 46 | 23 | 4 | M239 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.39e-06 | 76 | 23 | 4 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.46e-06 | 79 | 23 | 4 | M27643 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 9.53e-06 | 84 | 23 | 4 | M3228 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.62e-05 | 96 | 23 | 4 | M39834 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.00e-05 | 33 | 23 | 3 | M39503 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 6.25e-05 | 48 | 23 | 3 | M27642 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 7.74e-05 | 143 | 23 | 4 | M27275 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.39e-04 | 11 | 23 | 2 | M27372 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.62e-04 | 66 | 23 | 3 | MM15925 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.62e-04 | 66 | 23 | 3 | M18 | |
| Pathway | WP_FOCAL_ADHESION | 2.18e-04 | 187 | 23 | 4 | MM15913 | |
| Pathway | REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2 | 2.29e-04 | 14 | 23 | 2 | M27263 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.64e-04 | 15 | 23 | 2 | M27161 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.76e-04 | 199 | 23 | 4 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 2.76e-04 | 199 | 23 | 4 | M39402 | |
| Pathway | REACTOME_ATTACHMENT_AND_ENTRY | 4.28e-04 | 19 | 23 | 2 | M41729 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE | 4.75e-04 | 20 | 23 | 2 | M27258 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 5.53e-04 | 100 | 23 | 3 | M27158 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY | 6.31e-04 | 23 | 23 | 2 | M48234 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.56e-04 | 250 | 23 | 4 | M27554 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 6.88e-04 | 24 | 23 | 2 | M636 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 8.08e-04 | 26 | 23 | 2 | M708 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.08e-03 | 30 | 23 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.08e-03 | 30 | 23 | 2 | M39641 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 1.15e-03 | 31 | 23 | 2 | M685 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.15e-03 | 31 | 23 | 2 | MM1343 | |
| Pathway | WP_CANCER_PATHWAYS | 1.16e-03 | 507 | 23 | 5 | M48302 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.30e-03 | 33 | 23 | 2 | M6220 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.33e-03 | 302 | 23 | 4 | M39719 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.44e-03 | 532 | 23 | 5 | M27870 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.47e-03 | 140 | 23 | 3 | M587 | |
| Pathway | REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS | 1.64e-03 | 37 | 23 | 2 | M45028 | |
| Pathway | PID_FRA_PATHWAY | 1.64e-03 | 37 | 23 | 2 | M65 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.74e-03 | 325 | 23 | 4 | M12868 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.76e-03 | 326 | 23 | 4 | MM15917 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 2.01e-03 | 41 | 23 | 2 | M27257 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.03e-03 | 339 | 23 | 4 | M39736 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.42e-03 | 45 | 23 | 2 | MM15344 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 2.97e-03 | 50 | 23 | 2 | M678 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 3.85e-03 | 57 | 23 | 2 | M692 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 3.93e-03 | 198 | 23 | 3 | M18311 | |
| Pathway | PID_NOTCH_PATHWAY | 4.12e-03 | 59 | 23 | 2 | M17 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.40e-03 | 61 | 23 | 2 | M27103 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 5.13e-03 | 439 | 23 | 4 | M42563 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.43e-03 | 68 | 23 | 2 | M27303 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 6.07e-03 | 72 | 23 | 2 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 6.24e-03 | 73 | 23 | 2 | MM15906 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.19e-03 | 258 | 23 | 3 | MM14572 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.37e-03 | 85 | 23 | 2 | M16441 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 9.35e-03 | 90 | 23 | 2 | M631 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 9.75e-03 | 92 | 23 | 2 | MM14881 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.20e-12 | 15 | 31 | 5 | 15895400 | |
| Pubmed | 2.50e-12 | 175 | 31 | 8 | 28071719 | ||
| Pubmed | 1.06e-11 | 118 | 31 | 7 | 21078624 | ||
| Pubmed | 1.80e-11 | 7 | 31 | 4 | 7921537 | ||
| Pubmed | 4.69e-11 | 29 | 31 | 5 | 22613833 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 7.96e-11 | 79 | 31 | 6 | 18757743 | |
| Pubmed | 1.24e-10 | 167 | 31 | 7 | 22159717 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.70e-10 | 11 | 31 | 4 | 21524702 | |
| Pubmed | 9.33e-10 | 16 | 31 | 4 | 17601529 | ||
| Pubmed | 1.57e-09 | 18 | 31 | 4 | 11311202 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.08e-09 | 135 | 31 | 6 | 28675934 | |
| Pubmed | 2.48e-09 | 20 | 31 | 4 | 22911573 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 16219760 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 8081888 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 7670489 | ||
| Pubmed | 7.61e-09 | 26 | 31 | 4 | 24742657 | ||
| Pubmed | 9.79e-09 | 81 | 31 | 5 | 39217171 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.43e-08 | 1105 | 31 | 10 | 35748872 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 2.45e-08 | 560 | 31 | 8 | 21653829 | |
| Pubmed | 4.61e-08 | 608 | 31 | 8 | 16713569 | ||
| Pubmed | 5.37e-08 | 9 | 31 | 3 | 9693030 | ||
| Pubmed | 7.66e-08 | 10 | 31 | 3 | 9034910 | ||
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.05e-07 | 11 | 31 | 3 | 23472759 | |
| Pubmed | 1.40e-07 | 12 | 31 | 3 | 16750824 | ||
| Pubmed | 1.40e-07 | 12 | 31 | 3 | 26794322 | ||
| Pubmed | 1.40e-07 | 12 | 31 | 3 | 9396756 | ||
| Pubmed | 1.82e-07 | 13 | 31 | 3 | 12682087 | ||
| Pubmed | 1.82e-07 | 13 | 31 | 3 | 22222602 | ||
| Pubmed | 1.89e-07 | 146 | 31 | 5 | 27068509 | ||
| Pubmed | 2.39e-07 | 153 | 31 | 5 | 25037231 | ||
| Pubmed | 3.16e-07 | 64 | 31 | 4 | 22261194 | ||
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 3.56e-07 | 16 | 31 | 3 | 17948866 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 23571221 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 9010770 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 19907020 | ||
| Pubmed | Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. | 7.69e-07 | 2 | 31 | 2 | 25506919 | |
| Pubmed | Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits. | 7.69e-07 | 2 | 31 | 2 | 25190493 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 11810295 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 22961762 | ||
| Pubmed | Cellular and axonal constituents of neocortical molecular layer heterotopia. | 7.69e-07 | 2 | 31 | 2 | 25247689 | |
| Pubmed | Laminin-Dependent Interaction between Astrocytes and Microglia: A Role in Retinal Angiogenesis. | 7.69e-07 | 2 | 31 | 2 | 28697326 | |
| Pubmed | Laminin deficits induce alterations in the development of dopaminergic neurons in the mouse retina. | 7.69e-07 | 2 | 31 | 2 | 17711601 | |
| Pubmed | 8.44e-07 | 21 | 31 | 3 | 27856617 | ||
| Pubmed | Renal collecting system growth and function depend upon embryonic γ1 laminin expression. | 1.12e-06 | 23 | 31 | 3 | 21903675 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.98e-06 | 101 | 31 | 4 | 20551380 | |
| Pubmed | 2.07e-06 | 28 | 31 | 3 | 33953184 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 8113417 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 17426950 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 8012114 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 27375110 | ||
| Pubmed | Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. | 2.31e-06 | 3 | 31 | 2 | 16537560 | |
| Pubmed | Quantitative analysis of laminin 5 gene expression in human keratinocytes. | 2.31e-06 | 3 | 31 | 2 | 15854126 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 22563463 | ||
| Pubmed | Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. | 2.31e-06 | 3 | 31 | 2 | 17482449 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 18697739 | ||
| Pubmed | Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics. | 2.31e-06 | 3 | 31 | 2 | 16179086 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 15373767 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 17137774 | ||
| Pubmed | Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. | 2.31e-06 | 3 | 31 | 2 | 8833897 | |
| Pubmed | Expression and chain assembly of human laminin-332 in an insect cell-free translation system. | 2.31e-06 | 3 | 31 | 2 | 18603785 | |
| Pubmed | Laminin-5 suppresses chondrogenic differentiation of murine teratocarcinoma cell line ATDC5. | 2.31e-06 | 3 | 31 | 2 | 16165127 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 33179081 | ||
| Pubmed | Fibroblasts contribute to the deposition of laminin 5 in the extracellular matrix. | 2.31e-06 | 3 | 31 | 2 | 15149852 | |
| Pubmed | Differential expression of laminin-5 subunits during incisor and molar development in the mouse. | 2.31e-06 | 3 | 31 | 2 | 10853832 | |
| Pubmed | The spatiotemporal expression pattern of Syndecans in murine embryonic teeth. | 3.77e-06 | 34 | 31 | 3 | 32220631 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 10651091 | ||
| Pubmed | Jedi-1 and MEGF10 signal engulfment of apoptotic neurons through the tyrosine kinase Syk. | 4.61e-06 | 4 | 31 | 2 | 22993420 | |
| Pubmed | Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. | 4.61e-06 | 4 | 31 | 2 | 10806203 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 22673183 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 21034821 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 9645947 | ||
| Pubmed | Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility. | 4.61e-06 | 4 | 31 | 2 | 19940114 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 10801807 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 21283711 | ||
| Pubmed | 6.19e-06 | 40 | 31 | 3 | 27068110 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 7.67e-06 | 1201 | 31 | 8 | 35696571 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 14612440 | ||
| Pubmed | Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. | 7.68e-06 | 5 | 31 | 2 | 16581764 | |
| Pubmed | Laminin 5 regulates polycystic kidney cell proliferation and cyst formation. | 7.68e-06 | 5 | 31 | 2 | 16870608 | |
| Pubmed | Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). | 7.68e-06 | 5 | 31 | 2 | 11964076 | |
| Pubmed | IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. | 7.68e-06 | 5 | 31 | 2 | 9271670 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 16728390 | ||
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 15668394 | ||
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 1.15e-05 | 6 | 31 | 2 | 9506922 | |
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 20301304 | ||
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 19503073 | ||
| Pubmed | 1.22e-05 | 50 | 31 | 3 | 23658023 | ||
| Pubmed | 1.36e-05 | 164 | 31 | 4 | 32409323 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 1.61e-05 | 7 | 31 | 2 | 9004048 | |
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 37174615 | ||
| Pubmed | Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor. | 1.61e-05 | 7 | 31 | 2 | 19915564 | |
| Pubmed | Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. | 1.61e-05 | 7 | 31 | 2 | 11802174 | |
| Pubmed | 2.15e-05 | 8 | 31 | 2 | 8872465 | ||
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 2.15e-05 | 8 | 31 | 2 | 23529140 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 2.15e-05 | 8 | 31 | 2 | 9489770 | |
| Pubmed | 2.76e-05 | 9 | 31 | 2 | 12482924 | ||
| Pubmed | Semaphorin 6A in Retinal Ganglion Cells Regulates Functional Specialization of the Inner Retina. | 2.76e-05 | 9 | 31 | 2 | 38014224 | |
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 11784026 | ||
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 15623520 | ||
| Pubmed | 3.58e-05 | 210 | 31 | 4 | 16537572 | ||
| Interaction | FBXO2 interactions | 7.58e-09 | 411 | 31 | 9 | int:FBXO2 | |
| Interaction | ATN1 interactions | 1.15e-08 | 187 | 31 | 7 | int:ATN1 | |
| Interaction | CACNA1A interactions | 2.97e-08 | 123 | 31 | 6 | int:CACNA1A | |
| Interaction | IGFL3 interactions | 9.82e-08 | 75 | 31 | 5 | int:IGFL3 | |
| Interaction | ATXN7 interactions | 6.41e-07 | 109 | 31 | 5 | int:ATXN7 | |
| Interaction | HOXA1 interactions | 9.24e-07 | 356 | 31 | 7 | int:HOXA1 | |
| Interaction | ZFP41 interactions | 1.71e-06 | 57 | 31 | 4 | int:ZFP41 | |
| Interaction | GFI1B interactions | 1.92e-06 | 136 | 31 | 5 | int:GFI1B | |
| Interaction | PRG2 interactions | 4.15e-06 | 285 | 31 | 6 | int:PRG2 | |
| Interaction | NTN5 interactions | 6.53e-06 | 24 | 31 | 3 | int:NTN5 | |
| Interaction | NID2 interactions | 8.91e-06 | 86 | 31 | 4 | int:NID2 | |
| Interaction | EDN3 interactions | 2.20e-05 | 108 | 31 | 4 | int:EDN3 | |
| Interaction | FBLN1 interactions | 4.41e-05 | 129 | 31 | 4 | int:FBLN1 | |
| Interaction | TOP3B interactions | 4.43e-05 | 1470 | 31 | 10 | int:TOP3B | |
| Interaction | NID1 interactions | 5.44e-05 | 48 | 31 | 3 | int:NID1 | |
| Interaction | SLURP1 interactions | 6.77e-05 | 144 | 31 | 4 | int:SLURP1 | |
| Interaction | MFAP5 interactions | 6.92e-05 | 52 | 31 | 3 | int:MFAP5 | |
| Interaction | ZNF408 interactions | 6.95e-05 | 145 | 31 | 4 | int:ZNF408 | |
| Interaction | C1orf54 interactions | 1.20e-04 | 167 | 31 | 4 | int:C1orf54 | |
| Interaction | SDF2L1 interactions | 1.22e-04 | 322 | 31 | 5 | int:SDF2L1 | |
| Interaction | VWCE interactions | 1.29e-04 | 64 | 31 | 3 | int:VWCE | |
| Interaction | FBLN2 interactions | 1.41e-04 | 66 | 31 | 3 | int:FBLN2 | |
| Interaction | SCGB1A1 interactions | 1.50e-04 | 12 | 31 | 2 | int:SCGB1A1 | |
| Interaction | CCL3 interactions | 1.54e-04 | 178 | 31 | 4 | int:CCL3 | |
| Interaction | CDH23 interactions | 1.75e-04 | 71 | 31 | 3 | int:CDH23 | |
| Interaction | CRP interactions | 2.23e-04 | 77 | 31 | 3 | int:CRP | |
| Interaction | ST14 interactions | 2.74e-04 | 207 | 31 | 4 | int:ST14 | |
| Interaction | PI15 interactions | 2.79e-04 | 83 | 31 | 3 | int:PI15 | |
| Interaction | SIRPD interactions | 3.09e-04 | 86 | 31 | 3 | int:SIRPD | |
| Interaction | ELSPBP1 interactions | 3.77e-04 | 92 | 31 | 3 | int:ELSPBP1 | |
| Interaction | NUFIP2 interactions | 4.04e-04 | 417 | 31 | 5 | int:NUFIP2 | |
| Interaction | DEFB125 interactions | 4.28e-04 | 20 | 31 | 2 | int:DEFB125 | |
| Interaction | ZNF224 interactions | 4.28e-04 | 20 | 31 | 2 | int:ZNF224 | |
| Interaction | NOTCH4 interactions | 4.72e-04 | 21 | 31 | 2 | int:NOTCH4 | |
| Interaction | DEFA1 interactions | 4.82e-04 | 100 | 31 | 3 | int:DEFA1 | |
| Interaction | KLRG2 interactions | 5.56e-04 | 105 | 31 | 3 | int:KLRG2 | |
| Interaction | BMP1 interactions | 6.53e-04 | 111 | 31 | 3 | int:BMP1 | |
| Interaction | FBXO6 interactions | 6.83e-04 | 717 | 31 | 6 | int:FBXO6 | |
| Interaction | NOTCH3 interactions | 6.88e-04 | 113 | 31 | 3 | int:NOTCH3 | |
| Interaction | PROC interactions | 7.27e-04 | 26 | 31 | 2 | int:PROC | |
| Interaction | CAMKV interactions | 7.80e-04 | 118 | 31 | 3 | int:CAMKV | |
| Interaction | HLA-DPA1 interactions | 8.19e-04 | 120 | 31 | 3 | int:HLA-DPA1 | |
| Interaction | LLCFC1 interactions | 8.39e-04 | 121 | 31 | 3 | int:LLCFC1 | |
| Interaction | EFEMP1 interactions | 8.80e-04 | 123 | 31 | 3 | int:EFEMP1 | |
| Interaction | IL5RA interactions | 9.01e-04 | 124 | 31 | 3 | int:IL5RA | |
| Interaction | LOXL3 interactions | 9.06e-04 | 29 | 31 | 2 | int:LOXL3 | |
| Interaction | CFC1 interactions | 9.44e-04 | 126 | 31 | 3 | int:CFC1 | |
| Interaction | CBLN4 interactions | 9.66e-04 | 127 | 31 | 3 | int:CBLN4 | |
| Interaction | LAMC2 interactions | 9.70e-04 | 30 | 31 | 2 | int:LAMC2 | |
| Interaction | COL4A3 interactions | 9.70e-04 | 30 | 31 | 2 | int:COL4A3 | |
| Interaction | PRELP interactions | 1.10e-03 | 32 | 31 | 2 | int:PRELP | |
| Interaction | MSTN interactions | 1.17e-03 | 33 | 31 | 2 | int:MSTN | |
| Interaction | DLK2 interactions | 1.40e-03 | 36 | 31 | 2 | int:DLK2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 1.10e-03 | 681 | 31 | 4 | chr1p36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q32 | 1.97e-03 | 97 | 31 | 2 | chr7q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p22 | 2.26e-03 | 104 | 31 | 2 | chr2p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 1.93e-02 | 316 | 31 | 2 | chr3p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 2.03e-02 | 325 | 31 | 2 | chr9q34 | |
| GeneFamily | Laminin subunits | 4.29e-10 | 12 | 19 | 4 | 626 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 2.19e-05 | 7 | 19 | 2 | 570 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.22e-02 | 161 | 19 | 2 | 593 | |
| Coexpression | NABA_MATRISOME | PLXNA4 KCP LAMA3 LAMB2 HSPG2 LAMC2 LAMC3 HABP2 LTBP1 EGFL7 CRIM1 MEGF6 MEGF8 SSPOP AGRN MEGF10 | 3.56e-15 | 1008 | 31 | 16 | MM17056 |
| Coexpression | NABA_MATRISOME | PLXNA4 KCP LAMA3 LAMB2 HSPG2 LAMC2 LAMC3 HABP2 LTBP1 EGFL7 CRIM1 MEGF6 MEGF8 SSPOP AGRN MEGF10 | 4.69e-15 | 1026 | 31 | 16 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 4.17e-13 | 270 | 31 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 5.01e-13 | 275 | 31 | 10 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.41e-13 | 191 | 31 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.06e-12 | 196 | 31 | 9 | M3008 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 6.11e-12 | 40 | 31 | 6 | M5887 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 7.65e-09 | 20 | 31 | 4 | MM17053 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.40e-08 | 23 | 31 | 4 | M48001 | |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS | 6.16e-07 | 645 | 31 | 8 | M40158 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 3.14e-06 | 195 | 31 | 5 | M45684 | |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_1_DN | 8.29e-06 | 238 | 31 | 5 | M18841 | |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_DN | 1.79e-05 | 279 | 31 | 5 | M16867 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 2.43e-05 | 505 | 31 | 6 | M39167 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 3.25e-05 | 1106 | 31 | 8 | M39071 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS | 6.06e-05 | 595 | 31 | 6 | M40167 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 6.43e-05 | 365 | 31 | 5 | M39018 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 8.26e-05 | 385 | 31 | 5 | M39264 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP | 8.81e-05 | 200 | 31 | 4 | M7503 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | 1.02e-04 | 955 | 31 | 7 | M45680 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | 1.52e-04 | 704 | 31 | 6 | M45672 | |
| Coexpression | JONES_OVARY_NK_CELL | 1.59e-04 | 89 | 31 | 3 | M48353 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.97e-04 | 738 | 31 | 6 | MM17058 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | 2.16e-04 | 473 | 31 | 5 | M4306 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.16e-04 | 751 | 31 | 6 | M5885 | |
| Coexpression | JAEGER_METASTASIS_DN | 2.41e-04 | 260 | 31 | 4 | M10702 | |
| Coexpression | SINGH_KRAS_DEPENDENCY_SIGNATURE | 2.54e-04 | 20 | 31 | 2 | M2851 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 2.65e-04 | 780 | 31 | 6 | M2324 | |
| Coexpression | AIZARANI_LIVER_C10_MVECS_1 | 2.74e-04 | 269 | 31 | 4 | M39114 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 3.14e-04 | 805 | 31 | 6 | MM1067 | |
| Coexpression | TRAVAGLINI_LUNG_PERICYTE_CELL | 3.30e-04 | 114 | 31 | 3 | M41678 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 3.37e-04 | 284 | 31 | 4 | M16975 | |
| Coexpression | HU_FETAL_RETINA_RPE | 3.70e-04 | 291 | 31 | 4 | M39271 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 4.31e-04 | 303 | 31 | 4 | M39040 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS | 4.32e-04 | 26 | 31 | 2 | M47999 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 5.25e-04 | 574 | 31 | 5 | M39056 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | 5.30e-04 | 888 | 31 | 6 | M39049 | |
| Coexpression | DASU_IL6_SIGNALING_SCAR_UP | 6.16e-04 | 31 | 31 | 2 | M292 | |
| Coexpression | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN | 6.16e-04 | 31 | 31 | 2 | M3732 | |
| Coexpression | NABA_SECRETED_FACTORS | 6.49e-04 | 338 | 31 | 4 | MM17064 | |
| Coexpression | LI_PROSTATE_CANCER_EPIGENETIC | 6.57e-04 | 32 | 31 | 2 | M10861 | |
| Coexpression | NABA_SECRETED_FACTORS | 6.86e-04 | 343 | 31 | 4 | M5883 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN | 7.42e-04 | 34 | 31 | 2 | M27963 | |
| Coexpression | DESCARTES_MAIN_FETAL_MESOTHELIAL_CELLS | 7.42e-04 | 34 | 31 | 2 | M40115 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 7.86e-04 | 35 | 31 | 2 | MM17054 | |
| Coexpression | JONES_OVARY_ENDOTHELIAL | 9.17e-04 | 162 | 31 | 3 | M48350 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 8.57e-09 | 439 | 31 | 9 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 3.10e-06 | 450 | 31 | 7 | GSM777063_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 2.07e-05 | 398 | 31 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 3.47e-05 | 905 | 31 | 8 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 4.43e-05 | 456 | 31 | 6 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 4.59e-05 | 459 | 31 | 6 | GSM777037_500 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 5.02e-05 | 281 | 31 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 5.02e-05 | 281 | 31 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.65e-04 | 362 | 31 | 5 | JC_hmvEC_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100 | 2.39e-04 | 83 | 31 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 3.04e-04 | 90 | 31 | 3 | GSM777032_100 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_500 | 3.18e-04 | 417 | 31 | 5 | gudmap_kidney_adult_CortVasc_Tie2_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 3.90e-04 | 98 | 31 | 3 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | 4.61e-04 | 990 | 31 | 7 | JC_hmvEC_1000 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 4.65e-04 | 453 | 31 | 5 | GSM777067_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.05e-04 | 107 | 31 | 3 | JC_hmvEC_1000_K1 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.28e-04 | 466 | 31 | 5 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_200 | 5.58e-04 | 24 | 31 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k2 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.82e-09 | 183 | 31 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-09 | 192 | 31 | 6 | bcd8876235be503186f119653b39476488c0fa15 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-09 | 192 | 31 | 6 | f4cd65e6c5b17bcabf45fe5b687246c72e7975f7 | |
| ToppCell | Non-neuronal-Postmitotic-Mural|World / Primary Cells by Cluster | 4.52e-09 | 198 | 31 | 6 | dd38840a96171f58da243daa22b013e15a81db4a | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural|World / Primary Cells by Cluster | 4.52e-09 | 198 | 31 | 6 | 9fc1035ea447a4551a66944c869c4671e17cec61 | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural-18|World / Primary Cells by Cluster | 4.52e-09 | 198 | 31 | 6 | 21efb7bcd24f24d20791b34e75d6f9d46a129481 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-07 | 169 | 31 | 5 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-07 | 171 | 31 | 5 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.21e-07 | 172 | 31 | 5 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.35e-07 | 176 | 31 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.47e-07 | 179 | 31 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.64e-07 | 183 | 31 | 5 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-07 | 184 | 31 | 5 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-07 | 184 | 31 | 5 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-07 | 186 | 31 | 5 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-07 | 186 | 31 | 5 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.83e-07 | 187 | 31 | 5 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-07 | 187 | 31 | 5 | e60cbccf5842f25123fd34b9475759b7424b32e9 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.83e-07 | 187 | 31 | 5 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-07 | 187 | 31 | 5 | a178b1fed80a0bf83aedb6262493ee17374734b5 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-07 | 187 | 31 | 5 | 2b8eda2812be0be68a6f01aa4038925d3d5b1e65 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-07 | 188 | 31 | 5 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-07 | 188 | 31 | 5 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-07 | 188 | 31 | 5 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-07 | 188 | 31 | 5 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.93e-07 | 189 | 31 | 5 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | Globus_pallidus-Endothelial|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.93e-07 | 189 | 31 | 5 | ad7dc9d25edd68fb624380a082c389fe7d640e7d | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.93e-07 | 189 | 31 | 5 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 190 | 31 | 5 | 9d5242759546be0089981ef1877e4ed5f81face5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 190 | 31 | 5 | b7fc451e160e31dc898b122de844b501f587db67 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 190 | 31 | 5 | 83cc851fb9f644b17a8ebf4d99a646003769a22f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-07 | 190 | 31 | 5 | 9b0ad888eb20acc011904d8593bc32bdef18d050 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 190 | 31 | 5 | 5f440d4b334d66d419c03bd828f7d93f16c1ce67 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-07 | 191 | 31 | 5 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-07 | 192 | 31 | 5 | c157981b9a179925edcaabc0cb3b8805f0929004 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.09e-07 | 192 | 31 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-07 | 192 | 31 | 5 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-07 | 195 | 31 | 5 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Posterior_cortex-Endothelial|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.25e-07 | 195 | 31 | 5 | 988e3449691cc228cb55e5e30355136c97b12262 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-07 | 196 | 31 | 5 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 2.31e-07 | 196 | 31 | 5 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.31e-07 | 196 | 31 | 5 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-07 | 197 | 31 | 5 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-07 | 197 | 31 | 5 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 | |
| ToppCell | 390C-Endothelial_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-07 | 197 | 31 | 5 | aa381acea0f7882d39435a6f713386bf0588b5f8 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.37e-07 | 197 | 31 | 5 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-07 | 197 | 31 | 5 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-07 | 198 | 31 | 5 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-07 | 198 | 31 | 5 | f83956c4b13b5d0a0c6e3d9f580dbf99649ef175 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-07 | 198 | 31 | 5 | 5b5ccce5de82ea041465e656147cec3b8beb865b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-07 | 199 | 31 | 5 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-07 | 199 | 31 | 5 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.49e-07 | 199 | 31 | 5 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-07 | 199 | 31 | 5 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-07 | 199 | 31 | 5 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 2.55e-07 | 200 | 31 | 5 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-06 | 115 | 31 | 4 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-06 | 115 | 31 | 4 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-06 | 115 | 31 | 4 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.39e-06 | 159 | 31 | 4 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.46e-06 | 168 | 31 | 4 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.58e-06 | 169 | 31 | 4 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.58e-06 | 169 | 31 | 4 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.72e-06 | 170 | 31 | 4 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 170 | 31 | 4 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 170 | 31 | 4 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.85e-06 | 171 | 31 | 4 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.85e-06 | 171 | 31 | 4 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-06 | 172 | 31 | 4 | fc092a0631555d79e00ef9890cbd806e15bca2d4 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-06 | 172 | 31 | 4 | 745725bd10c82017d678463b8fef0d2dcf09a8fd | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.99e-06 | 172 | 31 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-06 | 173 | 31 | 4 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-06 | 173 | 31 | 4 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.27e-06 | 174 | 31 | 4 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.56e-06 | 176 | 31 | 4 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.56e-06 | 176 | 31 | 4 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.70e-06 | 177 | 31 | 4 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-06 | 178 | 31 | 4 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-06 | 178 | 31 | 4 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-06 | 179 | 31 | 4 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.16e-06 | 180 | 31 | 4 | fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 180 | 31 | 4 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-06 | 180 | 31 | 4 | e5c50d85e8df4e15f3e58f1f1d5aa25a375735de | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.16e-06 | 180 | 31 | 4 | c2a8f61c806f6f6f47743e9f7c9700705db43386 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.16e-06 | 180 | 31 | 4 | 178648429686e6d4e6f3aafc350130e819788ecf | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.16e-06 | 180 | 31 | 4 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 180 | 31 | 4 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-06 | 180 | 31 | 4 | f5d757786a3be20756ad8b30edd53ff80b824974 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.32e-06 | 181 | 31 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.32e-06 | 181 | 31 | 4 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | facs-Thymus-Epithelium-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-06 | 181 | 31 | 4 | bce56e12ab93693c9c04fa6aad8f2e1dff0c4d45 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 7.32e-06 | 181 | 31 | 4 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.32e-06 | 181 | 31 | 4 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-06 | 181 | 31 | 4 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.32e-06 | 181 | 31 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Mesenchymal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.32e-06 | 181 | 31 | 4 | c31a4386507877d59928398c8488856cd9c4b817 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Mesenchymal-Mes|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.32e-06 | 181 | 31 | 4 | ddd0d0e5c629ac0644922ace46b9ec6d64d30f43 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-06 | 182 | 31 | 4 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-06 | 182 | 31 | 4 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.48e-06 | 182 | 31 | 4 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| Computational | Ovary genes. | 1.46e-04 | 368 | 16 | 5 | MODULE_1 | |
| Computational | DRG (dorsal root ganglia) genes. | 1.79e-04 | 384 | 16 | 5 | MODULE_2 | |
| Computational | Trachea genes. | 2.57e-04 | 415 | 16 | 5 | MODULE_6 | |
| Computational | Placenta genes. | 4.27e-04 | 463 | 16 | 5 | MODULE_38 | |
| Computational | Neighborhood of CDH3 | 7.13e-04 | 27 | 16 | 2 | GNF2_CDH3 | |
| Computational | Neighborhood of SERPINB5 | 7.68e-04 | 28 | 16 | 2 | GNF2_SERPINB5 | |
| Computational | Adhesion molecules. | 1.09e-03 | 141 | 16 | 3 | MODULE_122 | |
| Computational | Genes in the cancer module 153. | 1.13e-03 | 34 | 16 | 2 | MODULE_153 | |
| Computational | Spinal cord (neuro-development) genes. | 1.64e-03 | 360 | 16 | 4 | MODULE_12 | |
| Computational | Genes in the cancer module 533. | 1.98e-03 | 45 | 16 | 2 | MODULE_533 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.44e-03 | 50 | 16 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.44e-03 | 50 | 16 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.44e-03 | 50 | 16 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Lung genes. | 3.24e-03 | 434 | 16 | 4 | MODULE_5 | |
| Computational | Intermediate filaments and MT. | 4.47e-03 | 68 | 16 | 2 | MODULE_438 | |
| Computational | Intermediate filaments. | 5.41e-03 | 75 | 16 | 2 | MODULE_154 | |
| Computational | Genes in the cancer module 297. | 6.14e-03 | 80 | 16 | 2 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 6.14e-03 | 80 | 16 | 2 | MODULE_357 | |
| Drug | AC1L1G72 | 9.21e-10 | 11 | 31 | 4 | CID000003553 | |
| Drug | 2,4-diaminopyrimidine | 1.01e-08 | 54 | 31 | 5 | CID000067431 | |
| Drug | kalinin | 1.11e-08 | 55 | 31 | 5 | CID000032518 | |
| Drug | LG 5 | 1.73e-08 | 60 | 31 | 5 | CID011840957 | |
| Drug | dysprosium | 5.03e-08 | 74 | 31 | 5 | CID000023912 | |
| Drug | chondroitin sulfate | 6.00e-08 | 413 | 31 | 8 | CID000024766 | |
| Drug | 2-amino-5-methylpyridine | 6.15e-08 | 77 | 31 | 5 | CID000015348 | |
| Drug | AC1L1B58 | 6.52e-08 | 29 | 31 | 4 | CID000001288 | |
| Drug | LMWH | 1.62e-07 | 663 | 31 | 9 | CID000000772 | |
| Drug | Calcort | 2.01e-07 | 38 | 31 | 4 | CID000026709 | |
| Drug | BM165 | 3.74e-07 | 11 | 31 | 3 | CID003352881 | |
| Drug | dermatan sulfate | 4.57e-07 | 220 | 31 | 6 | CID000032756 | |
| Drug | CC270 | 1.21e-06 | 59 | 31 | 4 | CID006918852 | |
| Drug | AC1L9INI | 1.21e-06 | 59 | 31 | 4 | CID000445839 | |
| Drug | hyaluronan | 1.30e-06 | 263 | 31 | 6 | CID000024759 | |
| Drug | ALT-711 | 2.99e-06 | 21 | 31 | 3 | CID000216304 | |
| Drug | YIGSR | 3.93e-06 | 79 | 31 | 4 | CID000123977 | |
| Drug | Sikvav | 4.54e-06 | 24 | 31 | 3 | CID005487517 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 4.79e-06 | 83 | 31 | 4 | CID011968896 | |
| Drug | Grgds | 4.79e-06 | 83 | 31 | 4 | CID000123811 | |
| Drug | NSC 714187 | 5.27e-06 | 85 | 31 | 4 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 5.52e-06 | 86 | 31 | 4 | CID000001322 | |
| Drug | poly-N-acetyllactosamine | 6.05e-06 | 88 | 31 | 4 | CID000119547 | |
| Drug | H-9 dihydrochloride | 6.62e-06 | 90 | 31 | 4 | CID000003544 | |
| Drug | Rgd Peptide | 1.66e-05 | 239 | 31 | 5 | CID000104802 | |
| Drug | Ikvav | 1.87e-05 | 38 | 31 | 3 | CID000131343 | |
| Drug | AC1O0B8G | 2.58e-05 | 262 | 31 | 5 | CID000091605 | |
| Drug | quinaprilat | 2.72e-05 | 43 | 31 | 3 | CID000107994 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 5.63e-05 | 155 | 31 | 4 | 6817_DN | |
| Drug | I-Q-S | 5.78e-05 | 156 | 31 | 4 | CID000003540 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 6.53e-05 | 161 | 31 | 4 | 3556_DN | |
| Drug | 2-amino-4,6-dinitrotoluene | 1.18e-04 | 70 | 31 | 3 | ctd:C035208 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 193 | 31 | 4 | 3262_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; HL60; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 2352_UP | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; HL60; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 3132_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 6830_UP | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 4507_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 2131_DN | |
| Drug | A0395 | 1.44e-04 | 75 | 31 | 3 | CID009906466 | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 5006_UP | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 6748_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.51e-04 | 200 | 31 | 4 | 5299_DN | |
| Drug | colchine | 1.56e-04 | 383 | 31 | 5 | CID000002833 | |
| Drug | cobalt-60 | 1.69e-04 | 390 | 31 | 5 | CID000061492 | |
| Drug | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | 1.85e-04 | 211 | 31 | 4 | ctd:C009618 | |
| Drug | AC1L9MFU | 1.88e-04 | 82 | 31 | 3 | CID000448874 | |
| Drug | lapatinib | 2.17e-04 | 86 | 31 | 3 | CID000208908 | |
| Drug | quinocetone | 3.43e-04 | 248 | 31 | 4 | ctd:C502851 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 3.20e-06 | 3 | 31 | 2 | cv:C0079683 | |
| Disease | Junctional epidermolysis bullosa | 3.20e-06 | 3 | 31 | 2 | cv:C0079301 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 3.20e-06 | 3 | 31 | 2 | 226700 | |
| Disease | Herlitz Disease | 6.40e-06 | 4 | 31 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 6.40e-06 | 4 | 31 | 2 | C0079297 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 1.07e-05 | 5 | 31 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 1.07e-05 | 5 | 31 | 2 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 1.07e-05 | 5 | 31 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 1.60e-05 | 6 | 31 | 2 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 2.24e-05 | 7 | 31 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Thrombophilia | 3.83e-05 | 9 | 31 | 2 | C0398623 | |
| Disease | dermatomyositis (is_marker_for) | 1.44e-04 | 17 | 31 | 2 | DOID:10223 (is_marker_for) | |
| Disease | Myasthenic Syndromes, Congenital | 2.91e-04 | 24 | 31 | 2 | C0751882 | |
| Disease | Encephalopathies | 3.69e-04 | 27 | 31 | 2 | C0085584 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 3.97e-04 | 28 | 31 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | Mental Retardation, Psychosocial | 4.17e-04 | 139 | 31 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 4.17e-04 | 139 | 31 | 3 | C0020796 | |
| Disease | Mental deficiency | 4.17e-04 | 139 | 31 | 3 | C0917816 | |
| Disease | 17-hydroxyprogesterone measurement | 4.26e-04 | 29 | 31 | 2 | EFO_0010220 | |
| Disease | Craniofacial Abnormalities | 5.84e-04 | 156 | 31 | 3 | C0376634 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 7.37e-04 | 169 | 31 | 3 | DOID:3908 (is_marker_for) | |
| Disease | cystatin C measurement | 7.98e-04 | 402 | 31 | 4 | EFO_0004617 | |
| Disease | fibroblast growth factor 23 measurement | 9.39e-04 | 43 | 31 | 2 | EFO_0009381 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ICQPPCRNGGSCVQP | 106 | Q9UHF1 | |
| PCQPNPCHGAAPCRV | 1591 | O00468 | |
| HPTVCPAGGRCQNQC | 1921 | Q96L73 | |
| PTCRDRPCQNGGQCH | 3846 | P98160 | |
| PCQLREPCLHGGTCQ | 4146 | P98160 | |
| PPGKHGPQCEQRCPC | 226 | Q96KG7 | |
| PHCPGACQRVEQGCA | 351 | Q5T089 | |
| PHCSPEGGQCPCQPN | 1276 | Q16787 | |
| GQPCPGRCICQNVAP | 31 | Q9P244 | |
| NCLNVPFGCCTPIHP | 46 | O95202 | |
| CQGPGQCTLRQHCPA | 826 | Q9HCM2 | |
| PCQGPTCQGQICHNT | 3726 | Q9NYQ8 | |
| CVPPCQNGGMCLRPQ | 191 | Q14766 | |
| HGRCVAPNQCQCVPG | 111 | Q5VY43 | |
| QPCQCGPGEKCHPET | 706 | Q5VY43 | |
| FHCTCPPGVQGRQCE | 756 | Q9UM47 | |
| GVPCQQTPRGPRCAC | 1301 | Q9UM47 | |
| LCPGGCQSHGQCQPP | 141 | Q7Z7M0 | |
| NPQQCPSPDQCHCDP | 1046 | P55268 | |
| CAPGPNGAECQCPHE | 2666 | P98164 | |
| PDRGQPCNSCREQCP | 21 | O43900 | |
| PCQPNPCEHGGDCLV | 76 | Q14520 | |
| VPVCRPNPCQNGATC | 151 | Q14520 | |
| ACSPQQEPQGCRCPL | 221 | Q8WZ55 | |
| PACGNPTIHPGQCCP | 646 | Q9NZV1 | |
| GEHGPVRPCQPCQCN | 506 | Q13753 | |
| CAGVNPVPCNCNPPV | 501 | Q3B820 | |
| VGPRCEQQCPQGHFG | 896 | O75095 | |
| SPAVPCRCCQEHGPG | 66 | Q9BVN2 | |
| CGPPVTPECEHCGQR | 376 | Q9NXH9 | |
| CNAIPGAPRCQCPAG | 256 | P07204 | |
| AEQCHQEGGPCPRLC | 2896 | A2VEC9 | |
| LHPCGQPCPRSCQDL | 3536 | A2VEC9 | |
| QECNLQPCPECPPGQ | 4811 | A2VEC9 | |
| CQEGHAHCQPRPCPR | 571 | Q6ZWJ8 | |
| SCAQPRQGPHDCCPQ | 1001 | Q6ZWJ8 | |
| VGGNCRRCDHAPNPC | 251 | Q9NR96 | |
| AGQADDCQPCPCPGQ | 746 | Q9Y6N6 |